Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

Jump to content

AP503

From Wikipedia, the free encyclopedia

AP503
Identifiers
  • methyl 3-[[2-(2,4-dimethylphenoxy)acetyl]amino]-4-(4-ethylpiperazin-1-yl)benzoate
CAS Number
PubChem CID
ChemSpider
Chemical and physical data
FormulaC24H31N3O4
Molar mass425.529 g·mol−1
3D model (JSmol)
  • CCN1CCN(CC1)C2=C(C=C(C=C2)C(=O)OC)NC(=O)COC3=C(C=C(C=C3)C)C
  • InChI=1S/C24H31N3O4/c1-5-26-10-12-27(13-11-26)21-8-7-19(24(29)30-4)15-20(21)25-23(28)16-31-22-9-6-17(2)14-18(22)3/h6-9,14-15H,5,10-13,16H2,1-4H3,(H,25,28)
  • Key:CPGGKKARFZXWMR-UHFFFAOYSA-N

AP503 is a chemical compound which acts as an agonist at the androgen receptor GPR133. It increases muscle growth and bone density in animal models, and may have potential applications in the treatment of osteoporosis and sarcopenia in the elderly.[1][2]

See also

[edit]

References

[edit]
  1. Yang Z, Ping YQ, Wang MW, Zhang C, Zhou SH, Xi YT, et al. (March 2025). "Identification, structure, and agonist design of an androgen membrane receptor". Cell. 188 (6): 1589–1604.e24. doi:10.1016/j.cell.2025.01.006. PMID 39884271.
  2. Lehmann J, Lin H, Zhang Z, Wiermann M, Ricken AM, Brinkmann F, et al. (June 2025). "The mechanosensitive adhesion G protein-coupled receptor 133 (GPR133/ADGRD1) enhances bone formation". Signal Transduction and Targeted Therapy. 10 (1) 199. doi:10.1038/s41392-025-02291-y. PMC 12206920. PMID 40583059.